Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Xiu Tang is active.

Publication


Featured researches published by Xiu Tang.


Neurology | 2014

PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.

Michael D. Nelson; Florian Rader; Xiu Tang; Jane Tavyev; Stanley F. Nelson; M. Carrie Miceli; Robert M. Elashoff; H. Lee Sweeney; Ronald G. Victor

Objective: To determine whether phosphodiesterase type 5 (PDE5) inhibition can alleviate exercise-induced skeletal muscle ischemia in boys with Duchenne muscular dystrophy (DMD). Methods: In 10 boys with DMD and 10 healthy age-matched male controls, we assessed exercise-induced attenuation of reflex sympathetic vasoconstriction, i.e., functional sympatholysis, a protective mechanism that matches oxygen delivery to metabolic demand. Reflex vasoconstriction was induced by simulated orthostatic stress, measured as the decrease in forearm muscle oxygenation with near-infrared spectroscopy, and performed when the forearm muscles were rested or lightly exercised with rhythmic handgrip exercise. Then, the patients underwent an open-label, dose-escalation, crossover trial with single oral doses of tadalafil or sildenafil. Results: The major new findings are 2-fold: first, sympatholysis is impaired in boys with DMD—producing functional muscle ischemia—despite contemporary background therapy with corticosteroids alone or in combination with cardioprotective medication. Second, PDE5 inhibition with standard clinical doses of either tadalafil or sildenafil alleviates this ischemia in a dose-dependent manner. Furthermore, PDE5 inhibition also normalizes the exercise-induced increase in skeletal muscle blood flow (measured by Doppler ultrasound), which is markedly blunted in boys with DMD. Conclusions: These data provide in-human proof of concept for PDE5 inhibition as a putative new therapeutic strategy for DMD. Classification of evidence: This study provides Class IV evidence that in patients with DMD, PDE5 inhibition restores functional sympatholysis.


Circulation | 2013

Cocaine-Induced Vasoconstriction in the Human Coronary Microcirculation New Evidence From Myocardial Contrast Echocardiography

Swaminatha V. Gurudevan; Michael D. Nelson; Florian Rader; Xiu Tang; Joshua Lewis; Jimmy Johannes; J. Todd Belcik; Robert M. Elashoff; Jonathan R. Lindner; Ronald G. Victor

Background— Cocaine is a major cause of acute coronary syndrome, especially in young adults; however, the mechanistic underpinning of cocaine-induced acute coronary syndrome remains limited. Previous studies in animals and in patients undergoing cardiac catheterization suggest that cocaine constricts coronary microvessels, yet direct evidence is lacking. Methods and Results— We used myocardial contrast echocardiography to test the hypothesis that cocaine causes vasoconstriction in the human coronary microcirculation. Measurements were performed at baseline and after a low, nonintoxicating dose of intranasal cocaine (2 mg/kg) in 10 healthy cocaine-naïve young men (median age, 32 years). Postdestruction time-intensity myocardial contrast echocardiography kinetic data were fit to the equation y=A(1−e−&bgr;t) to quantify functional capillary blood volume (A), microvascular flow velocity (&bgr;), and myocardial perfusion (A×&bgr;). Heart rate, mean arterial pressure, and left ventricular work (2-dimensional echocardiography) were measured before and 45 minutes after cocaine. Cocaine increased mean arterial pressure (by 14±2 mm Hg [mean±SE]), heart rate (by 8±3 bpm), and left ventricular work (by 50±18 mm Hg·mL−1·bpm−1). Despite the increases in these determinants of myocardial oxygen demand, myocardial perfusion decreased by 30% (103.7±9.8 to 75.9±10.8 arbitrary units [AU]/s; P<0.01) mainly as a result of decreased capillary blood volume (133.9±5.1 to 111.7±7.7 AU; P<0.05) with no significant change in microvascular flow velocity (0.8±0.1 to 0.7±0.1 AU). Conclusions— In healthy cocaine-naïve young adults, a low-dose cocaine challenge evokes a sizeable decrease in myocardial perfusion. Moreover, the predominant effect is to decrease myocardial capillary blood volume rather than microvascular flow velocity, suggesting a specific action of cocaine to constrict terminal feed arteries.Background— Cocaine is a major cause of acute coronary syndrome, especially in young adults; however, the mechanistic underpinning of cocaine-induced acute coronary syndrome remains limited. Previous studies in animals and in patients undergoing cardiac catheterization suggest that cocaine constricts coronary microvessels, yet direct evidence is lacking. Methods and Results— We used myocardial contrast echocardiography to test the hypothesis that cocaine causes vasoconstriction in the human coronary microcirculation. Measurements were performed at baseline and after a low, nonintoxicating dose of intranasal cocaine (2 mg/kg) in 10 healthy cocaine-naive young men (median age, 32 years). Postdestruction time-intensity myocardial contrast echocardiography kinetic data were fit to the equation y=A(1−e−βt) to quantify functional capillary blood volume (A), microvascular flow velocity (β), and myocardial perfusion (A×β). Heart rate, mean arterial pressure, and left ventricular work (2-dimensional echocardiography) were measured before and 45 minutes after cocaine. Cocaine increased mean arterial pressure (by 14±2 mm Hg [mean±SE]), heart rate (by 8±3 bpm), and left ventricular work (by 50±18 mm Hg·mL−1·bpm−1). Despite the increases in these determinants of myocardial oxygen demand, myocardial perfusion decreased by 30% (103.7±9.8 to 75.9±10.8 arbitrary units [AU]/s; P <0.01) mainly as a result of decreased capillary blood volume (133.9±5.1 to 111.7±7.7 AU; P <0.05) with no significant change in microvascular flow velocity (0.8±0.1 to 0.7±0.1 AU). Conclusions— In healthy cocaine-naive young adults, a low-dose cocaine challenge evokes a sizeable decrease in myocardial perfusion. Moreover, the predominant effect is to decrease myocardial capillary blood volume rather than microvascular flow velocity, suggesting a specific action of cocaine to constrict terminal feed arteries. # Clinical Perspective {#article-title-51}


The Journal of Physiology | 2015

Sodium nitrate alleviates functional muscle ischaemia in patients with Becker muscular dystrophy

Michael D. Nelson; Ryan Rosenberry; Rita Barresi; Evgeny Tsimerinov; Florian Rader; Xiu Tang; O'Neil Mason; Avery Schwartz; Thomas Stabler; Sarah Shidban; Neigena Mobaligh; Shomari Hogan; Robert M. Elashoff; Jason D. Allen; Ronald G. Victor

Dystrophin deficiency disrupts sarcolemmal targeting of neuronal nitric oxide synathase, resulting in functional muscle ischaemia. Chronic treatment of dystrophic mice with an inorganic nitric oxide (NO) donor alleviates this ischaemia and improves many features of the dystrophic phenotype. The present study translates this preclinical work by showing that a single oral dose of sodium nitrate,which serves as a NO donor when reduced to circulating nitrite by the commensal bacteria in the oral cavity, alleviates functional muscle ischaemia and restores normal blood flow regulation in human patients with dystrophinopathy. The results of the present study further support the mechanistic hypothesis that circulating nitrite serves as an alternative NO donor when reduced by deoxyhaemoglobin and/or deoxymyoglobin in exercising muscle.


Circulation | 2013

Cocaine-Induced Vasoconstriction in the Human Coronary MicrocirculationClinical Perspective: New Evidence From Myocardial Contrast Echocardiography

Swaminatha V. Gurudevan; Michael D. Nelson; Florian Rader; Xiu Tang; Joshua R. Lewis; Jimmy Johannes; J. Todd Belcik; Robert M. Elashoff; Jonathan R. Lindner; Ronald G. Victor

Background— Cocaine is a major cause of acute coronary syndrome, especially in young adults; however, the mechanistic underpinning of cocaine-induced acute coronary syndrome remains limited. Previous studies in animals and in patients undergoing cardiac catheterization suggest that cocaine constricts coronary microvessels, yet direct evidence is lacking. Methods and Results— We used myocardial contrast echocardiography to test the hypothesis that cocaine causes vasoconstriction in the human coronary microcirculation. Measurements were performed at baseline and after a low, nonintoxicating dose of intranasal cocaine (2 mg/kg) in 10 healthy cocaine-naïve young men (median age, 32 years). Postdestruction time-intensity myocardial contrast echocardiography kinetic data were fit to the equation y=A(1−e−&bgr;t) to quantify functional capillary blood volume (A), microvascular flow velocity (&bgr;), and myocardial perfusion (A×&bgr;). Heart rate, mean arterial pressure, and left ventricular work (2-dimensional echocardiography) were measured before and 45 minutes after cocaine. Cocaine increased mean arterial pressure (by 14±2 mm Hg [mean±SE]), heart rate (by 8±3 bpm), and left ventricular work (by 50±18 mm Hg·mL−1·bpm−1). Despite the increases in these determinants of myocardial oxygen demand, myocardial perfusion decreased by 30% (103.7±9.8 to 75.9±10.8 arbitrary units [AU]/s; P<0.01) mainly as a result of decreased capillary blood volume (133.9±5.1 to 111.7±7.7 AU; P<0.05) with no significant change in microvascular flow velocity (0.8±0.1 to 0.7±0.1 AU). Conclusions— In healthy cocaine-naïve young adults, a low-dose cocaine challenge evokes a sizeable decrease in myocardial perfusion. Moreover, the predominant effect is to decrease myocardial capillary blood volume rather than microvascular flow velocity, suggesting a specific action of cocaine to constrict terminal feed arteries.Background— Cocaine is a major cause of acute coronary syndrome, especially in young adults; however, the mechanistic underpinning of cocaine-induced acute coronary syndrome remains limited. Previous studies in animals and in patients undergoing cardiac catheterization suggest that cocaine constricts coronary microvessels, yet direct evidence is lacking. Methods and Results— We used myocardial contrast echocardiography to test the hypothesis that cocaine causes vasoconstriction in the human coronary microcirculation. Measurements were performed at baseline and after a low, nonintoxicating dose of intranasal cocaine (2 mg/kg) in 10 healthy cocaine-naive young men (median age, 32 years). Postdestruction time-intensity myocardial contrast echocardiography kinetic data were fit to the equation y=A(1−e−βt) to quantify functional capillary blood volume (A), microvascular flow velocity (β), and myocardial perfusion (A×β). Heart rate, mean arterial pressure, and left ventricular work (2-dimensional echocardiography) were measured before and 45 minutes after cocaine. Cocaine increased mean arterial pressure (by 14±2 mm Hg [mean±SE]), heart rate (by 8±3 bpm), and left ventricular work (by 50±18 mm Hg·mL−1·bpm−1). Despite the increases in these determinants of myocardial oxygen demand, myocardial perfusion decreased by 30% (103.7±9.8 to 75.9±10.8 arbitrary units [AU]/s; P <0.01) mainly as a result of decreased capillary blood volume (133.9±5.1 to 111.7±7.7 AU; P <0.05) with no significant change in microvascular flow velocity (0.8±0.1 to 0.7±0.1 AU). Conclusions— In healthy cocaine-naive young adults, a low-dose cocaine challenge evokes a sizeable decrease in myocardial perfusion. Moreover, the predominant effect is to decrease myocardial capillary blood volume rather than microvascular flow velocity, suggesting a specific action of cocaine to constrict terminal feed arteries. # Clinical Perspective {#article-title-51}


Circulation | 2013

Cocaine-Induced Vasoconstriction in the Human Coronary MicrocirculationClinical Perspective

Swaminatha V. Gurudevan; Michael D. Nelson; Florian Rader; Xiu Tang; Joshua R. Lewis; Jimmy Johannes; J. Todd Belcik; Robert M. Elashoff; Jonathan R. Lindner; Ronald G. Victor

Background— Cocaine is a major cause of acute coronary syndrome, especially in young adults; however, the mechanistic underpinning of cocaine-induced acute coronary syndrome remains limited. Previous studies in animals and in patients undergoing cardiac catheterization suggest that cocaine constricts coronary microvessels, yet direct evidence is lacking. Methods and Results— We used myocardial contrast echocardiography to test the hypothesis that cocaine causes vasoconstriction in the human coronary microcirculation. Measurements were performed at baseline and after a low, nonintoxicating dose of intranasal cocaine (2 mg/kg) in 10 healthy cocaine-naïve young men (median age, 32 years). Postdestruction time-intensity myocardial contrast echocardiography kinetic data were fit to the equation y=A(1−e−&bgr;t) to quantify functional capillary blood volume (A), microvascular flow velocity (&bgr;), and myocardial perfusion (A×&bgr;). Heart rate, mean arterial pressure, and left ventricular work (2-dimensional echocardiography) were measured before and 45 minutes after cocaine. Cocaine increased mean arterial pressure (by 14±2 mm Hg [mean±SE]), heart rate (by 8±3 bpm), and left ventricular work (by 50±18 mm Hg·mL−1·bpm−1). Despite the increases in these determinants of myocardial oxygen demand, myocardial perfusion decreased by 30% (103.7±9.8 to 75.9±10.8 arbitrary units [AU]/s; P<0.01) mainly as a result of decreased capillary blood volume (133.9±5.1 to 111.7±7.7 AU; P<0.05) with no significant change in microvascular flow velocity (0.8±0.1 to 0.7±0.1 AU). Conclusions— In healthy cocaine-naïve young adults, a low-dose cocaine challenge evokes a sizeable decrease in myocardial perfusion. Moreover, the predominant effect is to decrease myocardial capillary blood volume rather than microvascular flow velocity, suggesting a specific action of cocaine to constrict terminal feed arteries.Background— Cocaine is a major cause of acute coronary syndrome, especially in young adults; however, the mechanistic underpinning of cocaine-induced acute coronary syndrome remains limited. Previous studies in animals and in patients undergoing cardiac catheterization suggest that cocaine constricts coronary microvessels, yet direct evidence is lacking. Methods and Results— We used myocardial contrast echocardiography to test the hypothesis that cocaine causes vasoconstriction in the human coronary microcirculation. Measurements were performed at baseline and after a low, nonintoxicating dose of intranasal cocaine (2 mg/kg) in 10 healthy cocaine-naive young men (median age, 32 years). Postdestruction time-intensity myocardial contrast echocardiography kinetic data were fit to the equation y=A(1−e−βt) to quantify functional capillary blood volume (A), microvascular flow velocity (β), and myocardial perfusion (A×β). Heart rate, mean arterial pressure, and left ventricular work (2-dimensional echocardiography) were measured before and 45 minutes after cocaine. Cocaine increased mean arterial pressure (by 14±2 mm Hg [mean±SE]), heart rate (by 8±3 bpm), and left ventricular work (by 50±18 mm Hg·mL−1·bpm−1). Despite the increases in these determinants of myocardial oxygen demand, myocardial perfusion decreased by 30% (103.7±9.8 to 75.9±10.8 arbitrary units [AU]/s; P <0.01) mainly as a result of decreased capillary blood volume (133.9±5.1 to 111.7±7.7 AU; P <0.05) with no significant change in microvascular flow velocity (0.8±0.1 to 0.7±0.1 AU). Conclusions— In healthy cocaine-naive young adults, a low-dose cocaine challenge evokes a sizeable decrease in myocardial perfusion. Moreover, the predominant effect is to decrease myocardial capillary blood volume rather than microvascular flow velocity, suggesting a specific action of cocaine to constrict terminal feed arteries. # Clinical Perspective {#article-title-51}


American Journal of Cardiology | 2016

Acute Effect of Hookah Smoking on the Human Coronary Microcirculation.

Michael D. Nelson; Mary Rezk-Hanna; Florian Rader; O'Neil Mason; Xiu Tang; Sarah Shidban; Ryan Rosenberry; Neal L. Benowitz; Donald P. Tashkin; Robert Elashoff; Jonathan R. Lindner; Ronald G. Victor


Journal of the American College of Cardiology | 2015

TREATMENT WITH AN INORGANIC NITRIC OXIDE DONOR RECAPITULATES THE EFFECTS OF SARCOLEMMAL NNOS ON MUSCLE BLOOD FLOW REGULATION IN PATIENTS WITH BECKER MUSCULAR DYSTROPHY

Michael D. Nelson; O’Neil Mason; Florian Rader; Ryan Rosenberry; Avery Schwartz; Xiu Tang; Sarah Shidban; Neigena Mobaligh; Robert Elashoff; Thomas Stabler; Jason Allen; Evgeny Tsmirinov; Rita Barresi; Ronald G. Victor


The FASEB Journal | 2014

Dietary sodium nitrate supplementation restores blood flow regulation in Becker muscular dystrophy (1165.1)

Michael D. Nelson; Florian Rader; Xiu Tang; Thomas Stabler; Jason D. Allen; Ronald G. Victor


Circulation | 2014

Abstract 18830: Sodium Nitrate Recapitulates Sarcolemmal nNOS and Alleviates Functional Muscle Ischemia in Patients With Becker Muscular Dystrophy

Michael D. Nelson; Florian Rader; Xiu Tang; Thomas Stabler; Sarah Shidban; Ryan Rosenberry; Shomari Hogan; Robert M. Elashoff; Jason D. Allen; Ronald G. Victor


The FASEB Journal | 2013

Phosphodiesterase 5 inhibition rescues functional sympatholysis in Duchenne Muscular Dystrophy

Michael D. Nelson; Elizabeth A. Martin; Xiu Tang; Jimmy Johannes; Joshua R. Lewis; Swaminatha V. Gurudevan; Stanley F. Nelson; Carrie M. Miceli; Ronald G. Victor

Collaboration


Dive into the Xiu Tang's collaboration.

Top Co-Authors

Avatar

Michael D. Nelson

University of Texas at Arlington

View shared research outputs
Top Co-Authors

Avatar

Ronald G. Victor

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar

Florian Rader

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jimmy Johannes

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ryan Rosenberry

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar

Sarah Shidban

Cedars-Sinai Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge